European Randomised Study of TOOKAD ® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up
Condition: Cancer of the Prostate Intervention: Other: no intervention (post study follow up) Sponsors: Steba Biotech S.A.; International Drug Development Institute; ICON plc Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials